The levels of all transcripts, except COL3a1 on IPF cells, were increased in both normal and IPF cultures treated with the anti-LOXL2 antibody over the course of the culture time (Figure 6C). The gene discussed is COL3A1; the disease is idiopathic pulmonary fibrosis.